PulseAugur
EN
LIVE 20:01:07
ENTITY Axiom Biosciences

Axiom Biosciences

PulseAugur coverage of Axiom Biosciences — every cluster mentioning Axiom Biosciences across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-07-21 funding Axiom Biosciences plans an initial public offering (IPO) in Hong Kong by 2027, aiming to raise at least $200 million. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_155065 ·

    US biotech Axiom plans Hong Kong IPO for AI therapies

    Axiom Biosciences, a US-based biotechnology firm specializing in AI-driven therapies for infant brain injuries, is planning an initial public offering (IPO) in Hong Kong by 2027. The company aims to raise at least $200 …